Bluejay Diagnostics, Inc. Prepaid Expense and Other Assets, Current
Bluejay Diagnostics, Inc. (BJDX) had Prepaid Expense and Other Assets, Current of $202.97 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $202.97K.
- 2026-03-31: Prepaid Expense and Other Assets, Current $269.94K.
- 2025-12-31: Prepaid Expense and Other Assets, Current $275.96K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $169.42K.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $202.97K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $269.94K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $275.96K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $169.42K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $305.48K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $456.08K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $596.94K 10-K · filed 2026-03-06 |
| 2024-09-30 | $811.95K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $959.99K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $788.58K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $747.26K 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.45M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.48M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.12M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.67M 10-K · filed 2024-03-28 |
| 2022-09-30 | $646.89K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $1.04M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $1.30M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.61M 10-K · filed 2023-03-20 |
| 2021-09-30 | $451.41K 10-Q · filed 2021-12-16 |
| 2020-12-31 | $61.07K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |